Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Guidelines for management of patients with chronic heart failure in Australia
Autore:
Krum, H;
Indirizzi:
Natl Heart Fdn Australia, Melbourne, Vic, Australia Natl Heart Fdn Australia Melbourne Vic Australia lbourne, Vic, Australia
Titolo Testata:
MEDICAL JOURNAL OF AUSTRALIA
fascicolo: 9, volume: 174, anno: 2001,
pagine: 459 - 466
SICI:
0025-729X(20010507)174:9<459:GFMOPW>2.0.ZU;2-L
Fonte:
ISI
Lingua:
ENG
Soggetto:
CONVERTING-ENZYME-INHIBITOR; LEFT-VENTRICULAR DYSFUNCTION; RANDOMIZED TRIAL; MYOCARDIAL-INFARCTION; DOUBLE-BLIND; CARDIOVASCULAR MORBIDITY; VASODILATOR THERAPY; ELDERLY PATIENTS; MORTALITY; HYPERTENSION;
Tipo documento:
Editorial Material
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
67
Recensione:
Indirizzi per estratti:
Indirizzo: Krum, H Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Clin Pharmacol Unit, Prahran, Vic 3181, Australia Monash Univ Prahran Vic Australia 3181 ahran, Vic 3181, Australia
Citazione:
H. Krum, "Guidelines for management of patients with chronic heart failure in Australia", MED J AUST, 174(9), 2001, pp. 459-466

Abstract

. Chronic heart failure (CHF) affects approximately 1% of people aged 50-59 years, and this high prevalence increases dramatically with age.. CHF is a common reason for hospital admission and general practitioner consultation in the elderly.. Common causes of CHF are ischaemic heart disease, hypertension and idiopathic dilated cardiomyopathy.. Diagnosis of CHF is based on clinical features and objective measurementof ventricular function leg, echocardiography).. Management is directed at prevention, retarding disease progression, relief of symptoms and prolonging survival.. Non-pharmacological approaches include exercise, home-based support and risk-factor modification.. Angiotensin-converting enzyme (ACE) inhibitors are the cornerstone of pharmacological therapy to prevent disease progression and prolong survival.. beta -Blockers prolong survival when added to ACE inhibitors in symptomatic patients.. Diuretics provide symptom relief and restoration or maintenance of euvolaemia.. Spironolactone, angiotensin II receptor antagonists and digoxin may be useful in some patients. Surgical approaches in highly selected patients mayinclude myocardial revascularisation, insertion of devices and cardiac transplantation.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/03/20 alle ore 19:40:39